Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

City of Hope Physicians and Researchers Announce Breakthroughs at AACR 2018

April 19, 2018 | Leticia Marquez

City of Hope scientists and doctors presented their latest cancer research at the annual meeting of the American Association for Cancer Research at Chicago’s McCormick Place on April 14 to 18.

CAR T Laboratory Research Yields Promising Prostate Cancer Results

April 17, 2018 | Letisia Marquez

City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.

Sound Therapy: TGen Tests Ultrasound to Enhance Cancer Drug Delivery

March 26, 2018 | City of Hope

City of Hope affiliate TGen has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.

Leukemia Drug Shows Promise Against Rare Ovarian Cancer

March 2, 2018 | City of Hope

City of Hope affiliate TGen has found that an anti-cancer drug used to fight leukemia shows promise against SCCOHT, a rare and aggressive type of ovarian cancer.

With New CAR T Approach, City of Hope CEACAM Research Comes Full Circle

February 9, 2018 | Jyoti Madhusoodanan

CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and CEACAMs, have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.

Nonsmokers and Lung Cancer: What You Should Know

December 21, 2017 | Alison Shore

The widely held assumption that lung cancer is caused by smoking is fairly accurate: 85 percent of cases are smoking induced. But 15 percent of lung cancers are not related to smoking.

Inside the Lab: Preventing breast cancer from invading the brain

July 24, 2017 | Denise Heady

A study led by City of Hope neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., offers novel insights on how cancer cells in HER2-positive breast cancer develop the ability to break through the blood-brain barrier and, ultimately, how they can be stopped.

Load More